期刊
JOURNAL OF MEDICAL VIROLOGY
卷 81, 期 12, 页码 2029-2035出版社
WILEY
DOI: 10.1002/jmv.21583
关键词
HCV subtype; interferon; ribavirin
类别
资金
- Agence Nationale de Recherche Contre le SIDA et les Hepatites Virales (ANRS)
The hepatitis C virus genotype is considered to be the most important baseline predictor of a sustained virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin. The influence of the subtype on the sustained virological response was investigated in patients infected with genotypes 1, 4, 5, or 6. This study was done on 597 patients with chronic hepatitis C who were given pegylated interferon and ribavirin for 48 weeks. The overall rate of sustained virological response in the 597 patients was 37.8%. Univariate analysis indicated that the sustained virological response of patients infected with subtype 1b (39%) tended to be higher than that of patients infected with subtype la (30.6%; P=0.06) and it was similar to those patients infected with subtypes 4a (51.3%; P=0.12) or 4d (51.7%; P=0.16). Multivariate analysis indicated that five factors were independently associated with sustained virological response: the age (OR 0.97; 95% CI = 0.95-0.99), absence of cirrhosis (OR: 2.92; 95% CI = 1.7-5.0; P<0.01), absence of HIV co-infection (OR: 2.08; 95% CI = 1.2-3.5; P<0.01), low baseline plasma HCV RNA concentration (OR: 1.74; 95% CI = 1.2-2.6; P< 0.01), and the subtype 1b (OR: 1.61; 95% CI = 1.0-2.5; P=0.04) or subtypes 4a and 4d (OR: 2.03; 95% CI = 1.1-3.8; P=0.03). In conclusion, among difficult-to-treat genotypes, the subtype la is associated with a lower response to anti-HCV therapy than subtypes 1b, 4a, and 4d. J. Med. Virol. 81:2029-2035, 2009. (C) 2009 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据